88 related articles for article (PubMed ID: 15006365)
1. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein.
Yin H; Hamilton AD
Bioorg Med Chem Lett; 2004 Mar; 14(6):1375-9. PubMed ID: 15006365
[TBL] [Abstract][Full Text] [Related]
2. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183
[TBL] [Abstract][Full Text] [Related]
3. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
4. Bcl-xl and Bak protein expression in human optic nerve axons in eyeballs post-trauma and in the eyes with absolute glaucoma.
Reszeć J; Zalewska R; Mariak Z; Sulkowski S
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():19-21. PubMed ID: 15638362
[TBL] [Abstract][Full Text] [Related]
5. [The expression of Bcl-2, Bcl-xl, Bak and Bax proteins in axons of the optic nerve in closed-angle glaucoma].
Zalewska R; Reszeć J; Mariak Z; Sulkowski S
Klin Oczna; 2004; 106(1-2 Suppl):155-7. PubMed ID: 15510481
[TBL] [Abstract][Full Text] [Related]
6. Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry.
Kutzki O; Park HS; Ernst JT; Orner BP; Yin H; Hamilton AD
J Am Chem Soc; 2002 Oct; 124(40):11838-9. PubMed ID: 12358513
[TBL] [Abstract][Full Text] [Related]
7. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the membrane orientation and secondary structure of the C-terminal domains of Bak and Bcl-2 by lipids.
Torrecillas A; Martínez-Senac MM; Goormaghtigh E; de Godos A; Corbalán-García S; Gómez-Fernández JC
Biochemistry; 2005 Aug; 44(32):10796-809. PubMed ID: 16086582
[TBL] [Abstract][Full Text] [Related]
9. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
Petros AM; Nettesheim DG; Wang Y; Olejniczak ET; Meadows RP; Mack J; Swift K; Matayoshi ED; Zhang H; Thompson CB; Fesik SW
Protein Sci; 2000 Dec; 9(12):2528-34. PubMed ID: 11206074
[TBL] [Abstract][Full Text] [Related]
10. Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex.
Ernst JT; Becerril J; Park HS; Yin H; Hamilton AD
Angew Chem Int Ed Engl; 2003 Feb; 42(5):535-9. PubMed ID: 12569483
[No Abstract] [Full Text] [Related]
11. Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface.
Rodriguez JM; Ross NT; Katt WP; Dhar D; Lee GI; Hamilton AD
ChemMedChem; 2009 Apr; 4(4):649-56. PubMed ID: 19330783
[TBL] [Abstract][Full Text] [Related]
12. A system based on specific protein-RNA interactions for analysis of target protein-protein interactions in vitro: successful selection of membrane-bound Bak-Bcl-xL proteins in vitro.
Sawata SY; Suyama E; Taira K
Protein Eng Des Sel; 2004 Jun; 17(6):501-8. PubMed ID: 15292519
[TBL] [Abstract][Full Text] [Related]
13. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.
Sattler M; Liang H; Nettesheim D; Meadows RP; Harlan JE; Eberstadt M; Yoon HS; Shuker SB; Chang BS; Minn AJ; Thompson CB; Fesik SW
Science; 1997 Feb; 275(5302):983-6. PubMed ID: 9020082
[TBL] [Abstract][Full Text] [Related]
14. Bak but not Bax is essential for Bcl-xS-induced apoptosis.
Lindenboim L; Kringel S; Braun T; Borner C; Stein R
Cell Death Differ; 2005 Jul; 12(7):713-23. PubMed ID: 15861188
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of inhibin on apoptosis and apoptosis related proteins in human ovarian granulosa cells.
Denkova R; Bourneva V; Staneva-Dobrovski L; Zvetkova E; Baleva K; Yaneva E; Nikolov B; Ivanov I; Simeonov K; Timeva T; Yankov M
Endocr Regul; 2004 Jun; 38(2):51-5. PubMed ID: 15497928
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of Bak derived peptides: affinity and specificity modulations by amino acid replacement.
Frey V; Viaud J; Subra G; Cauquil N; Guichou JF; Casara P; Grassy G; Chavanieu A
Eur J Med Chem; 2008 May; 43(5):966-72. PubMed ID: 17692431
[TBL] [Abstract][Full Text] [Related]
18. Bcl-X(L) specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum.
Klee M; Pimentel-Muiños FX
J Cell Biol; 2005 Feb; 168(5):723-34. PubMed ID: 15728194
[TBL] [Abstract][Full Text] [Related]
19. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
20. A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak.
Kvansakul M; van Delft MF; Lee EF; Gulbis JM; Fairlie WD; Huang DC; Colman PM
Mol Cell; 2007 Mar; 25(6):933-42. PubMed ID: 17386268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
